Concepedia

Andy Billinton

AB

Statistics

Publications

18

Citations

934

H-Index

15

Active since

2004

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (Sweden)

Andy Billinton is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, medicine, and drug discovery.

Publications per year

2004–2023

18

Publications

18

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

Penny C. Staton, Jon P. Hatcher, Deborah J. Walker et al. · Pain · 2008 · 271 citations

, , +16

Comparative cellular distribution of GABA<sub>A</sub> and GABA<sub>B</sub> receptors in the human basal ganglia: Immunohistochemical colocalization of the α<sub>1</sub> subunit of the GABA<sub>A</sub> receptor, and the GABA<sub>B</sub>R1 and GABA<sub>B</sub>R2 receptor subunits

Henry J. Waldvogel, Andy Billinton, Julia H. White et al. · The Journal of Comparative Neurology · 2004 · 87 citations

, , +15

Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain

Stephen J. Medhurst, S D Collins, Andy Billinton et al. · Pain · 2008 · 85 citations

, , +15

Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy

Adrian Hall, Andy Billinton, Susan H. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 76 citations · Full text

, , +13

Discovery and structure–activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor

Muna Abdi, Paul Beswick, Andy Billinton et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 70 citations · Full text

, , +13

1–5 of 18